ABT 263-d8
ABT 263-d8
CAS: 1217620-38-6
Molecular Formula: C47H55ClF3N5O6S3
ABT 263-d8 - Names and Identifiers
ABT 263-d8 - Physico-chemical Properties
| Molecular Formula | C47H55ClF3N5O6S3 |
| Molar Mass | 974.6127096 |
| Melting Point | 102-107°C |
| Solubility | Chloroform (Slightly), DMSO (Slightly) |
| Appearance | Solid |
| Color | White to Pale Yellow |
| Storage Condition | -20°C Freezer, Under Inert Atmosphere |
ABT 263-d8 - Introduction
ABT 263-d8(ABT 263-d8) is a pharmaceutical compound that is a deuterated marker for the ABT-263 of inhibitors of the Bcl-2 family of proteins that promote apoptosis. It is a compound with a Deuterium label, and its chemical properties and ABT-263 are very similar.
ABT 263-d8 is mainly used to study drug metabolism, drug delivery, pharmacokinetics and pharmacokinetics. It also has some potential in cancer therapy, as the Bcl-2 protein family is overexpressed in many cancer cells, which can lead to uncontrolled cell proliferation and survival.
The method for preparing ABT 263-d8 mainly includes using deuterated reagents or replacing some hydrogen atoms with deuterated reagents during the synthesis process to synthesize ABT 263-d8 with deuterated labels.
Regarding safety information, as ABT 263-d8 is a laboratory drug, there is currently no detailed safety information publicly available for reference. However, as a chemical, it can be toxic and dangerous. During use and handling, the laboratory safety procedures must be strictly followed and the recommendations in the safety data sheet (SDS) of the chemical must be followed. To ensure safety, it is recommended that ABT 263-d8 be used under the guidance of professionally instructed and trained personnel.
ABT 263-d8 is mainly used to study drug metabolism, drug delivery, pharmacokinetics and pharmacokinetics. It also has some potential in cancer therapy, as the Bcl-2 protein family is overexpressed in many cancer cells, which can lead to uncontrolled cell proliferation and survival.
The method for preparing ABT 263-d8 mainly includes using deuterated reagents or replacing some hydrogen atoms with deuterated reagents during the synthesis process to synthesize ABT 263-d8 with deuterated labels.
Regarding safety information, as ABT 263-d8 is a laboratory drug, there is currently no detailed safety information publicly available for reference. However, as a chemical, it can be toxic and dangerous. During use and handling, the laboratory safety procedures must be strictly followed and the recommendations in the safety data sheet (SDS) of the chemical must be followed. To ensure safety, it is recommended that ABT 263-d8 be used under the guidance of professionally instructed and trained personnel.
Last Update：2024-04-09 20:45:29
Supplier List
Product Name: ABT 263-d8 Visit Supplier Webpage Request for quotation
CAS: 1217620-38-6
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
CAS: 1217620-38-6
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
Product Name: ABT 263-d8 Visit Supplier Webpage Request for quotation
CAS: 1217620-38-6
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
CAS: 1217620-38-6
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
View History